MTOR and primary central nervous system lymphoma: mTOR, a serine/threonine protein kinase, belongs to the PI3K-related kinase family and is an essential downstream target of the BCR signaling pathway (50).Therefore, targeting key components of PI3K/AKT/mTOR signaling may represent a potential treatment for the PCNSL (50).